Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Lymphoma, also known as malignant lymphoma, is a general term for a group of malignant tumors originating from the lymphopoietic system. It is one of the most common tumors in China. In 2020, there were 544,352 new cases of non-Hodgkin lymphoma (NHL) worldwide, ranking 13th among all new cases of malignancies.

Genomic Health reported recently that its fourth quarter revenues rose 22 percent year over year, beating the consensus Wall Street estimate of $101.5 million. For the three months ended Dec. 31, 2018, the companys total revenues were $104.6

Recently, the Wall Street Journal reported that Swiss biopharmaceutical company Roche is acquiring US technology company Spark Theraputics, which may be announced on Monday. The acquisition will value Sparks nearly $5 billion, while the Nasd

Danaher Corporation announced that it has entered into a definitive agreement with General Electric to acquire GE Life Sciences GE Biopharma business with a cash purchase price of approximately $21.4 billion. Given the expected tax benefits

Icon, an international drug-development and commercialization services firm, has acquired MolecularMD for an undisclosed amount, the companies said recently. MolecularMD, based in Portland, Oregon, is a molecular diagnostic laboratory that s

Exact Sciences reported after the close of the market recently that its fourth quarter revenues rose 64 percent year over year, thanks to a 66 percent increase in the number of completed Cologuard colorectal cancer tests during the quarter.

GenMark Diagnostics reported after the close of the market recently that its fourth quarter revenues rose 21 percent year over year,in line withpreliminary Q4 revenuesreported in January. For the three months ended Dec. 31, 2018, the company

Agilent Technologies reported after the close of the market on Wednesday that its first quarter 2019 revenues rose 6 percent year over year, thanks largely to a 13 percent increase in revenues in its diagnostics and genomics business. For th

Thermo Fisher Scientific today reported an 8 percent increase in fourth quarter revenues, driven by growth across its four business segments. The company, headquartered in Waltham, Massachusetts, reported Q4 revenues of $6.51 billion, up 8 p

Thermo Fisher Scientific has acquired a 9 percent stake in molecular diagnostic company Yourgene Health by exercising warrants it held in the company. In addition, Thermo Fisher has further warrants that, if exercised, could take its ownersh

PerkinElmer announced after the close of the market on Thursday that its fourth quarter revenues rose 18 percent year over year. For the three months ended Dec. 30, 2018, the company posted revenues of $756.3 million compared to $641.6 milli